title: An assessment of the use of Implanon in three community services.
abstract: OBJECTIVE
  The aims of the study were three-fold, namely to assess continuation rates with Implanon fitted in clients from three contraception and sexual health services; to identify factors associated with early removal of Implanon; and to assess clinician compliance with recommended practice in counselling and insertion.
  
  
  METHODS
  Retrospective review of client records, and comparison with audit criteria. Postal survey.
  
  
  RESULTS
  One hundred and ninety women had Implanon inserted in the study period. Continuation rates were between 84% and 88% at 6 months and 67% and 78% at 12 months. There were no pregnancies or procedure complications. The main reasons for removal were identified as intolerance of recognised side effects or a change of mind about wanting contraception. Younger women were more likely to have the device removed early. There was evidence of excellent or good recording of many criteria for best practice in counselling and insertion. The assessment highlighted certain issues around counselling and insertion that services needed to consider further.
  
  
  CONCLUSIONS
  The three services have been reassured that they are providing a good standard of care to clients requesting Implanon and that their 'real life' 6- and 12-month continuation rates are reasonable.
authors.affiliation: North Derbyshire Contraception & Sexual Health Service, Chesterfield, UK.
authors.forename: Amanda
authors.initials: A
authors.lastname: Smith
authors.forename: Simone
authors.initials: S
authors.lastname: Reuter
mesh_terms: D000293:Adolescent; D000328:Adult; D003151:Community Health Centers; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D017135:Desogestrel; D020878:Device Removal; D004343:Drug Implants; D005260:Female; D006801:Humans; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D012189:Retrospective Studies; D014753:Vinyl Compounds / Q000627:therapeutic use*
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; D014753:Vinyl Compounds; C044815:etonogestrel; D017135:Desogestrel